ライフサイエンスコーパス: study design

1 Study design and adherence to quality criteria had a consider

2 Study design, sampling method, assessment methods, and interp

3 The working group developed recommendations regarding (1) study design; (2) data security, access, and sharing; (3) leg

4 planted post January 1, 2009 and followed the original 2018 study design.

5 er 60 min on days 1 and 15 of a 28-day cycle in a rolling 6 study design with de-escalation upon dose-limiting toxicities

6 era trap-based experiments using a case study, we propose a study design that integrates observational and experimental t

7 etter understand differences in estimated RSV burden across study design.

8 current evidence, we then recommend several statistical and study design approaches that may help untangle issues of bidi

9 he methodological issues, focusing on the interplay between study design, analysis strategy, and the fact that outcomes m

10 e considerations on manufacturing parameter dominance, both study design and scale have been optimised to enable statisti

11 By study design, PET/CT scans were performed at baseline and bef

12 cal three-factor (treatment, microbiome and outcome) causal study design.

13 This study used a cohort study design of 3229 ARIC participants enrolled at the Minnes

14 We used a new user-active comparator study design and identified patients with a first hospitaliza

15 These results highlight the importance of considering study design and medical history when designing prospective c

16 The case-control study design has evolved substantially over the past half cen

17 t show that a statistical framework called the case-control study design, commonly used in epidemiology but rarely applie

18 genome-wide association studies (GWAS) with a case-control study design.

19 Although the current study design does not allow causality to be inferred, it does

20 age (GA) from May 2015 to December 2017, with the following study design: phase I, 2-minute resting state at baseline (ro

21 Pooled analyses after adjustment for study design found that FGM/C was associated with dyspareunia

22 se of standardized outcomes and time horizons, and improved study design and statistical methodology.

23 nce of accounting for nitrate-independent effects of BRJ in study design and interpretation.

24 ts necessary for their successful implementation, including study design principles, analytical tools and future developm

25 ditions by actively incorporating biological variation into study design through diversifying study samples and condition

26 resenting a diverse array of subject matter, investigators, study design, institutions, and countries.

27 Here, we use a longitudinal study design spanning from childhood to adolescence, where pa

28 Using a longitudinal study design, we found contrasting effects of schistosome inf

29 riments or studies; explanations of whether key elements of study design, such as sample size and choice of specific stat

30 cancer was identified for the variables of sex, smoking or study design.

31 paid careful attention to critical aspects of the original study design and took into account receptor saturation and pr

32 Other study design variables, such as age of animals and dietary co

33 Our study design allowed for orthogonal validation and replicatio

34 Pivotal study design differences between experimental studies and cli

35 II and level III studies have variable primary end points, study design limitations, and only short-term follow-up data.

36 ry best practices and recommendations related to prediction study design, conduct, and reporting.

37 Using a matched-pair cluster randomized study design (ClinicalTrials.gov: NCT02776254), 10 clinics we

38 influenced biological model selection, concentration range, study design, and hypothesis testing.

39 A cross-sectional study design was used.

40 DESIGN, SETTING, PARTICIPANTS: Serial cross-sectional study design, using National Health and Nutrition Examination

41 line, cost-effective participant recruitment and selection, study design, outcomes and dissemination of results.

42 The study design is a retrospective cohort study.

43 The study design, year, patient's demographics, mean time between

44 We describe in detail the study design, recruitment, data collection, lessons learned,

45 There was high heterogeneity in the study design and inconsistency of the reported outcomes; ther

46 timates of mortality varied substantially, depending on the study design and statistical method.

47 ed approach to aligning a clinical trial objective with the study design, including endpoints and analysis.

48 h careful examination of the theoretical properties of this study design, we provide key insights that can directly infor

49 d study questions and following a comprehensive approach to study design and data analysis in which questions guide the c

50 Using a unique study design documenting adult dispersal from natural larval